Market closed
Ginkgo Bioworks/$DNA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Ginkgo Bioworks
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
Ticker
$DNA
Sector
Trading on
NYSE
Industry
Chemicals
Headquarters
Employees
1,218
Website
Ginkgo Bioworks Metrics
BasicAdvanced
$585M
Market cap
-
P/E ratio
-$12.86
EPS
1.10
Beta
-
Dividend rate
Price and volume
Market cap
$585M
Beta
1.1
52-week high
$75.20
52-week low
$5.26
Average daily volume
1.3M
Financial strength
Current ratio
5.79
Quick ratio
5.594
Long term debt to equity
55.843
Total debt to equity
55.843
Interest coverage (TTM)
-5,681.02%
Management effectiveness
Return on assets (TTM)
-19.19%
Return on equity (TTM)
-63.51%
Valuation
Price to revenue (TTM)
2.571
Price to book
0.73
Price to tangible book (TTM)
0.82
Price to free cash flow (TTM)
-1.447
Growth
Revenue change (TTM)
-30.81%
Earnings per share change (TTM)
-28.40%
3-year revenue growth (CAGR)
3.36%
3-year earnings per share growth (CAGR)
14.64%
Ginkgo Bioworks News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Ginkgo Bioworks stock?
Ginkgo Bioworks (DNA) has a market cap of $585M as of December 12, 2024.
What is the P/E ratio for Ginkgo Bioworks stock?
The price to earnings (P/E) ratio for Ginkgo Bioworks (DNA) stock is 0 as of December 12, 2024.
Does Ginkgo Bioworks stock pay dividends?
No, Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders as of December 12, 2024.
When is the next Ginkgo Bioworks dividend payment date?
Ginkgo Bioworks (DNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Ginkgo Bioworks?
Ginkgo Bioworks (DNA) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.